Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests ...

In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish ...

Shares of Edwards Lifesciences Corp. EW advanced 2.94% to $73.22 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to ...

Piper Sandler analyst Adam Maeder maintained a Hold rating on Resmed (RMD – Research Report) today and set a price target of $260.00. The ...

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Airbnb, Inc. (ABNB) and Royal Caribbean Cruises Ltd. (RCL), as well a micro-cap ...

MedTekon 2025, the flagship event of the Medical Technology Association of India (MTaI), convened policymakers, global ...

SMS Lifesciences India Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 380.99 Crore) operating in Pharmaceuticals sector. SMS Lifesciences India Ltd. key ...

Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...